IHAM
NVO

Integral Health Asset Management’s Novo Nordisk NVO Stock Holding History

Integral Health Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400,000
Closed -$22.2M – 98
2025
Q3 		$22.2M Buy
+400,000
New +$23.4M 1.5% 20
2023
Q3 		– Sell
-500,000
Closed -$40.5M – 83
2023
Q2 		$40.5M Buy
+500,000
New +$40.8M 5.01% 3

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Integral Health Asset Management's NVO Position: Q2 2020 in Review

Integral Health Asset Management sold out of Novo Nordisk (NVO) in Q2 2020, closing a stake of 110,000 shares — an estimated $3.31M sold.

Integral Health Asset Management first reported a position in NVO in Q4 2019 and held it in 2 quarters. The position peaked at $3.31M in Q1 2020. 661 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

  • Integral Health Asset Management reported no remaining Novo Nordisk position as of Q2 2020 after selling out during the quarter.
  • Integral Health Asset Management sold 110,000 Novo Nordisk shares in Q2 2020, an estimated $3.31M.
  • Integral Health Asset Management first reported a position in Novo Nordisk in Q4 2019 and held it in 2 quarters.
  • Integral Health Asset Management's Novo Nordisk position peaked at $3.31M in Q1 2020.
  • 661 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Integral Health Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.